Hypersensitivity of bladder low threshold, wide dynamic range, afferent fibres following treatment with the chemotherapeutic drugs cyclophosphamide and ifosfamide-Reference-Cited by-同舟云学术

Hypersensitivity of bladder low threshold, wide dynamic range, afferent fibres following treatment with the chemotherapeutic drugs cyclophosphamide and ifosfamide

Published:2020-05-22 Issue:8 Volume:94 Page:2785-2797
ISSN:0340-5761
Container-title:Archives of Toxicology
language:en
Short-container-title:Arch Toxicol

Author:

Mills Kylie A.,West Eleanor J.,Grundy Luke,McDermott Catherine,Sellers Donna J.,Rose’Myer Roselyn B.,Chess-Williams Russ^ORCID

Funder

Cancer Council Queensland

Bond University

Publisher

Springer Science and Business Media LLC

Subject

Health, Toxicology and Mutagenesis,Toxicology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00204-020-02773-8.pdf

Reference52 articles.

1. Andersson M, Tobin G, Giglio D (2008) Cholinergic nitric oxide release from the urinary bladder mucosa in cyclophosphamide-induced cystitis of the anaesthetized rat. Br J Pharmacol 153(7):1438–1444

2. Beckel JM, Birder LA (2012) Differential expression and function of nicotinic acetylcholine receptors in the urinary bladder epithelium of the rat. J Physiol 590(6):1465–1480

3. Bergh J (2003) Best use of adjuvant systemic therapies II, chemotherapy aspects: dose of chemotherapy–cytotoxicity, duration and responsiveness. Breast 12(6):529–537

4. Brucker C, Sieg P (1999) Effect of combined carboplatin and ifosfamide with local hyperthermia on human mouth carcinoma in the animal model. Mund Kiefer Gesichtschir 3(Suppl 1):S144–S146

5. Buda A, Dell'Anna T, Signorelli M, Mangioni C (2003) Role of ifosfamide in cervical cancer: an overview. Oncology 65(Suppl 2):63–66

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pathophysiology of Overactive Bladder and Pharmacologic Treatments Including β3-Adrenoceptor Agonists -Basic Research Perspectives-;International Neurourology Journal;2024-02-29

2. BCG induced lower urinary tract symptoms during treatment for NMIBC—Mechanisms and management strategies;Frontiers in Neuroscience;2024-01-08

3. Animal models of interstitial cystitis/bladder pain syndrome;Frontiers in Physiology;2023-09-04

4. Pathophysiological Mechanisms Involved in Overactive Bladder/Detrusor Overactivity;Current Bladder Dysfunction Reports;2023-02-28

5. TRPV1 and TRPM8 antagonists reduce cystitis‐induced bladder hypersensitivity via inhibition of different sensitised classes of bladder afferents in guinea pigs;British Journal of Pharmacology;2023-01-13